Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Leukemia, Myeloid, Chronic-Phase MeSH Descriptor Data 2026


MeSH Heading
Leukemia, Myeloid, Chronic-Phase
Tree Number(s)
C04.557.337.539.250.400
C15.378.190.636.370.400
C15.378.508.539.250.400
C23.550.291.500.485.400
Unique ID
D015466
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015466
Scope Note
The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.
Entry Version
CML CHRONIC
Entry Term(s)
Granulocytic Leukemia, Chronic, Stable Phase
Granulocytic Leukemia, Chronic, Stable-Phase
Leukemia, Granulocytic, Chronic Phase
Leukemia, Granulocytic, Chronic-Phase
Leukemia, Myelogenous, Chronic Phase
Leukemia, Myelogenous, Chronic-Phase
Leukemia, Myeloid, Chronic Phase
Leukemia, Myeloid, Stable Phase
Leukemia, Myeloid, Stable-Phase
Myelogenous Leukemia, Chronic, Chronic Phase
Myelogenous Leukemia, Chronic, Chronic-Phase
Myeloid Leukemia, Chronic, Chronic Phase
Myeloid Leukemia, Chronic, Chronic-Phase
Myeloid Leukemia, Chronic, Stable-Phase
Previous Indexing
Leukemia, Myelocytic (1972-1988)
Leukemia, Myeloid (1972-1988)
Public MeSH Note
89
History Note
89
Date Introduced
1989/01/01
Last Updated
2023/05/31
Leukemia, Myeloid, Chronic-Phase Preferred
page delivered in 0.148s